Covalon Technologies (OTCMKTS:CVALF) Trading 4.6% Higher – Time to Buy?

Covalon Technologies Ltd. (OTCMKTS:CVALF) shares traded up 4.6% on Wednesday . The company traded as high as $1.56 and last traded at $1.5375. Approximately 4,208 shares changed hands during trading, a decline of 56% from the average session volume of 9,632 shares. The stock had previously closed at $1.47.

Covalon Technologies Trading Up 4.6%

The stock’s 50-day simple moving average is $1.50 and its 200-day simple moving average is $1.36. The firm has a market capitalization of $42.47 million, a P/E ratio of 38.45 and a beta of 0.63.

Covalon Technologies (OTCMKTS:CVALF) last posted its earnings results on Thursday, May 21st. The company reported $0.03 EPS for the quarter, topping the consensus estimate of $0.01 by $0.02. Covalon Technologies had a net margin of 5.05% and a return on equity of 5.77%. The firm had revenue of $6.27 million for the quarter, compared to analysts’ expectations of $6.70 million.

About Covalon Technologies

Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.

The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.